Results 121 to 130 of about 1,669,562 (240)

MR-Guided Adaptive Radiotherapy in Localized Prostate Cancer

open access: yes
MR-guided radiotherapy (MRgRT) is novel treatment modality in Radiation Oncology that could allow a higher precision and tolerability of Radiation Treatments.
Antonio De Simone BS   +13 more
core   +1 more source

Survival after first relapse in marginal zone lymphomas: Prospective data from the international observational NF10 study

open access: yesBritish Journal of Haematology, EarlyView.
Summary While marginal zone lymphoma (MZL) is generally indolent, outcomes following relapse remain poorly defined. This study utilized the indolent Non Follicular 10 (NF10) prospective database to characterize survival and identify prognostic drivers in patients failing initial systemic therapy. The study analysed 122 patients with relapsed MZL.
Stefano Luminari   +28 more
wiley   +1 more source

A pro‐inflammatory cytokine signature characterises thrombotic antiphospholipid syndrome despite stable anticoagulation

open access: yesBritish Journal of Haematology, EarlyView.
Primary antiphospholipid syndrome comprises distinct inflammatory subgroups defined by cytokine profiling. A shared pro‐inflammatory signature is present across all patients, whereas arterial thrombosis demonstrates enhanced inflammatory activation compared with venous thrombosis, suggesting divergent pathogenic mechanisms and opportunities for ...
Catherine B. Ducker   +6 more
wiley   +1 more source

Magnetic resonance-guided adaptive stereotactic radiotherapy in prostate cancer patients: a systematic literature review

open access: yesReports of Practical Oncology and Radiotherapy
Objective: Magnetic resonance-guided adaptive stereotactic radiotherapy (MRgRT) represents an innovative approach in radiation oncology, combining real-time MR imaging with treatment delivery systems.
Sylwia Szablewska, Krzysztof Roszkowski
doaj   +1 more source

Dynamic risk stratification using early CAR‐T expansion in R/R LBCL treated with axicabtagene ciloleucel

open access: yesBritish Journal of Haematology, EarlyView.
Higher chimeric antigen receptor‐T expansion at day 7 is associated with improved progression‐free survival but also increased toxicity in axi‐cel treated patients with R/R large B‐cell lymphoma, independent of other baseline patient and disease characteristics.
Brydon Panozzo   +17 more
wiley   +1 more source

A phase IIa study of the anti‐PD‐L1 antibody avelumab in relapsed/refractory PTCL: The AVAIL‐T trial

open access: yesBritish Journal of Haematology, EarlyView.
The AVAIL‐T study, the first evaluation of programmed death ligand 1 (PD‐L1) blockade in relapsed/refractory peripheral T‐cell lymphomas (PTCL), demonstrated limited single agent activity with durable responses seen in a minority. Circulating tumour DNA revealed distinct mutational dynamics and mass cytometry identified perturbed T‐cell subsets ...
Matthew J. Ahearne   +28 more
wiley   +1 more source

Editorial: Radiation therapy using MRI-Linac - the right way to start: a guide for physicians and physicists

open access: yesFrontiers in Oncology, 2023
Enis Özyar   +3 more
doaj   +1 more source

Development of in-house software to process real-time cine magnetic resonance images acquired during 1.5 T MR-guided radiation therapy

open access: yesScientific Reports
This study aimed to develop and publicly release an in-house software package that converts the binary file format of 2D cine magnetic resonance (MR) images acquired through the Treatment Session Manager (TSM) of MOSAIQ on the Elekta Unity (Elekta AB ...
Jiwon Sung   +4 more
doaj   +1 more source

Symptom‐guided reduction of BCG dwell time: findings from the north‐REG randomized trial

open access: yesBJU International, EarlyView.
Objectives To evaluate the impact of personalized dwell‐time (DT) reductions on symptom prevalence and systemic toxicities in patients undergoing Bacillus Calmette–Guérin (BCG) instillation for non‐muscle invasive bladder cancer (NMIBC). Methods Within a multinational randomized controlled trial (North‐REG Dwell Time Study [NCT04701151]), 225 patients ...
Lene Munk   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy